Company comparison
Synopsys vs Cadence Design Systems
Radar profile, momentum bars, and stack placement side by side.
Synopsys
Not scored
momentum
Cadence Design Systems
Not scored
momentum
Synopsys capital
—
Cadence Design Systems capital
—
No radar series.
Momentum head-to-head
Attribute tape
| Field | Synopsys | Cadence Design Systems |
|---|---|---|
| Category | Semiconductors and hardware | Semiconductors and hardware |
| Stack | Layer 1 | Layer 1 |
| HQ | Sunnyvale, CA, United States | San Jose, CA, United States |
| Founded | 1986 | 1988 |
| Status | Operating | Operating |
| Funding | — | — |
| Momentum | — | — |
| Summary | Synopsys is the leading provider of electronic design automation (EDA) software, semiconductor IP, and verification tools used by chip designers and system developers worldwide. Its solutions span the full semiconductor stack from RTL design and physical implementation through simulation, formal verification, and software security analysis. | Cadence Design Systems is a leading provider of electronic design automation (EDA) software, hardware-assisted verification, semiconductor IP, and AI-driven system design tools used to create chips, PCBs, and complex electronic systems. It also extends its computational intelligence platform into molecular sciences for drug discovery. |
| Who for | Teams evaluating AI vendors in this category. | Teams evaluating AI vendors in this category. |
| Differentiator | Synopsys is the leading provider of electronic design automation (EDA) software, semiconductor IP, and verification tools used by chip designers and system developers worldwide. Its solutions span the full semiconductor stack from RTL design and physical implementation through simulation, formal verification, and software security analysis. | Cadence Design Systems is a leading provider of electronic design automation (EDA) software, hardware-assisted verification, semiconductor IP, and AI-driven system design tools used to create chips, PCBs, and complex electronic systems. It also extends its computational intelligence platform into molecular sciences for drug discovery. |
